AR062715A1 - Procesos para la preparacion de acidos de 1,2,4- oxadiazol benzoico - Google Patents

Procesos para la preparacion de acidos de 1,2,4- oxadiazol benzoico

Info

Publication number
AR062715A1
AR062715A1 ARP070103975A ARP070103975A AR062715A1 AR 062715 A1 AR062715 A1 AR 062715A1 AR P070103975 A ARP070103975 A AR P070103975A AR P070103975 A ARP070103975 A AR P070103975A AR 062715 A1 AR062715 A1 AR 062715A1
Authority
AR
Argentina
Prior art keywords
substituted
formula
unsubstituted
compound
benzoico
Prior art date
Application number
ARP070103975A
Other languages
English (en)
Spanish (es)
Original Assignee
Ptc Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ptc Therapeutics Inc filed Critical Ptc Therapeutics Inc
Publication of AR062715A1 publication Critical patent/AR062715A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ARP070103975A 2006-09-08 2007-09-07 Procesos para la preparacion de acidos de 1,2,4- oxadiazol benzoico AR062715A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84359506P 2006-09-08 2006-09-08

Publications (1)

Publication Number Publication Date
AR062715A1 true AR062715A1 (es) 2008-11-26

Family

ID=38935880

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP070103975A AR062715A1 (es) 2006-09-08 2007-09-07 Procesos para la preparacion de acidos de 1,2,4- oxadiazol benzoico
ARP170100223A AR107474A2 (es) 2006-09-08 2017-01-27 Proceso para la preparación de un ácido de 1,2,4-oxadiazol benzoico
ARP200101362A AR118922A2 (es) 2006-09-08 2020-05-12 Procesos para la preparación de ácidos de 1,2,4-oxadiazol benzoico

Family Applications After (2)

Application Number Title Priority Date Filing Date
ARP170100223A AR107474A2 (es) 2006-09-08 2017-01-27 Proceso para la preparación de un ácido de 1,2,4-oxadiazol benzoico
ARP200101362A AR118922A2 (es) 2006-09-08 2020-05-12 Procesos para la preparación de ácidos de 1,2,4-oxadiazol benzoico

Country Status (24)

Country Link
US (2) US7678922B2 (enExample)
EP (1) EP2059513B1 (enExample)
JP (2) JP5955494B2 (enExample)
KR (1) KR101466368B1 (enExample)
CN (1) CN101535284B (enExample)
AR (3) AR062715A1 (enExample)
AU (1) AU2007292915B2 (enExample)
BR (1) BRPI0716996B8 (enExample)
CA (2) CA2842625C (enExample)
CL (1) CL2007002606A1 (enExample)
DK (1) DK2059513T3 (enExample)
ES (1) ES2404348T3 (enExample)
IL (1) IL197445A (enExample)
MX (1) MX2009002439A (enExample)
MY (1) MY148598A (enExample)
NZ (2) NZ598012A (enExample)
PE (2) PE20120669A1 (enExample)
PL (1) PL2059513T3 (enExample)
PT (1) PT2059513E (enExample)
RU (1) RU2495030C2 (enExample)
TW (1) TWI482761B (enExample)
UA (1) UA99265C2 (enExample)
WO (1) WO2008030570A1 (enExample)
ZA (1) ZA200901782B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3178816A1 (en) 2003-04-11 2017-06-14 PTC Therapeutics, Inc. 1,2,4-oxadiazole benzoic acid compound and its use for nonsense suppression and the treatment of disease
JP5800451B2 (ja) 2005-04-08 2015-10-28 ピーティーシー セラピューティクス,インコーポレーテッド ナンセンス突然変異抑制治療用の、経口的に活性な1,2,4−オキサジアゾール組成物
CN101505739A (zh) * 2006-03-30 2009-08-12 Ptc医疗公司 由具有无义突变的dna生产功能蛋白的方法以及相关疾病的治疗
DK2059513T3 (da) * 2006-09-08 2013-05-06 Ptc Therapeutics Inc Fremgangsmåde til fremstillingen af 1,2,4-oxadiazolbenzoesyrer
AU2007300542B2 (en) * 2006-09-25 2012-05-17 Ptc Therapeutics, Inc. Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid
WO2008130370A1 (en) 2006-09-25 2008-10-30 Ptc Therapeutics, Inc. Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and the use for nonsense suppression
EP2073805B1 (en) 2006-10-12 2015-03-04 PTC Therapeutics, Inc. Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
CN101714009A (zh) * 2009-05-14 2010-05-26 翁印嵩 集成通用电话功能的计算机
EP2668951B9 (en) 2011-01-25 2017-03-15 Viviabiotech, S.L. 1,2,4-oxadiazole derivatives as drugs modulating the glp-1 peptide receptor
ES2782509T3 (es) 2012-07-02 2020-09-15 Monsanto Technology Llc Procedimiento para la preparación de 1,2,4-oxadiazoles 3,5-disustituidos
TWI636978B (zh) 2014-03-06 2018-10-01 美商Ptc治療公司 1,2,4-二唑苯甲酸之鹽及醫藥組合物
CN105461650B (zh) * 2014-09-12 2018-04-13 杭州普晒医药科技有限公司 一种噁二唑化合物的溶剂化物及其制备方法
CN106316885B (zh) * 2015-07-03 2019-02-12 普济生物科技(台州)有限公司 一种3-[5-(2-氟苯基)-1,2,4-噁二唑-3-基]苯甲酸的制备方法
KR20180081516A (ko) 2015-10-30 2018-07-16 피티씨 테라퓨틱스, 인크. 간질 치료 방법
TW201808922A (zh) 2016-06-20 2018-03-16 台灣神隆股份有限公司 製備阿塔魯仁及其中間體的方法
US12268669B2 (en) 2018-12-20 2025-04-08 Pfizer Inc. Pharmaceutical compositions and methods comprising a combination of a benzoxazole transthyretin stabilizer and an additional therapeutic agent
KR20210151131A (ko) 2019-04-10 2021-12-13 피티씨 테라퓨틱스, 인크. 소아 환자에서 넌센스 돌연변이 매개된 뒤센 근이영양증의 치료 방법
WO2022112919A1 (en) 2020-11-25 2022-06-02 Pfizer Inc. (aza)benzothiazolyl substituted pyrazole compounds
CN113045510B (zh) * 2021-03-31 2022-05-27 北京大学生命科学华东产业研究院 一种阿塔鲁伦的制备方法
CN114920667B (zh) * 2022-06-30 2024-06-21 湖南大学 一种阿塔鲁伦酯的电化学制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801509A1 (de) * 1978-01-12 1979-07-19 Schering Ag 1,2,4-oxadiazolderivate, verfahren zur herstellung dieser verbindungen sowie diese enthaltende selektive herbizide mittel
DE3905242A1 (de) * 1989-02-21 1990-08-23 Basf Ag Verfahren zur herstellung von phenyloxdiazolylanilinen
NZ234760A (en) * 1989-08-18 1991-09-25 Sterling Drug Inc Antiviral oxazole compounds and compositions
DE4425794A1 (de) * 1994-07-21 1996-01-25 Basf Ag Nitrofarbstoffe
US6660753B2 (en) 1999-08-19 2003-12-09 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
AU2002313633B2 (en) 2001-06-08 2007-03-01 Cytovia, Inc. Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
MY151199A (en) 2001-11-02 2014-04-30 Rigel Pharmaceuticals Inc Substituted diphenyl heterocycles useful for treating hcv infection
US20040132726A1 (en) 2002-08-09 2004-07-08 Astrazeneca Ab And Nps Pharmaceuticals, Inc. New compounds
GB0303503D0 (en) 2003-02-14 2003-03-19 Novartis Ag Organic compounds
EP3178816A1 (en) 2003-04-11 2017-06-14 PTC Therapeutics, Inc. 1,2,4-oxadiazole benzoic acid compound and its use for nonsense suppression and the treatment of disease
US20050075375A1 (en) 2003-05-14 2005-04-07 Anadys Pharmaceuticals, Inc. Heterocyclic compounds for treating hepatitis C virus
JP5800451B2 (ja) 2005-04-08 2015-10-28 ピーティーシー セラピューティクス,インコーポレーテッド ナンセンス突然変異抑制治療用の、経口的に活性な1,2,4−オキサジアゾール組成物
DK2059513T3 (da) * 2006-09-08 2013-05-06 Ptc Therapeutics Inc Fremgangsmåde til fremstillingen af 1,2,4-oxadiazolbenzoesyrer

Also Published As

Publication number Publication date
NZ575511A (en) 2012-02-24
BRPI0716996B8 (pt) 2021-05-25
ZA200901782B (en) 2010-06-30
PE20080771A1 (es) 2008-06-13
EP2059513B1 (en) 2013-01-23
WO2008030570A1 (en) 2008-03-13
AR118922A2 (es) 2021-11-10
CA2662749A1 (en) 2008-03-13
ES2404348T3 (es) 2013-05-27
HK1134094A1 (en) 2010-04-16
CA2842625A1 (en) 2008-03-13
BRPI0716996B1 (pt) 2021-02-09
TW200823180A (en) 2008-06-01
PL2059513T3 (pl) 2013-06-28
KR101466368B1 (ko) 2014-11-27
PE20120669A1 (es) 2012-06-01
AR107474A2 (es) 2018-05-02
US20100063297A1 (en) 2010-03-11
CL2007002606A1 (es) 2008-04-18
US7678922B2 (en) 2010-03-16
NZ598012A (en) 2013-08-30
DK2059513T3 (da) 2013-05-06
IL197445A0 (en) 2009-12-24
JP5955494B2 (ja) 2016-07-20
CA2662749C (en) 2015-01-20
EP2059513A1 (en) 2009-05-20
RU2009113019A (ru) 2010-10-20
IL197445A (en) 2014-01-30
BRPI0716996A2 (pt) 2013-10-08
UA99265C2 (ru) 2012-08-10
CN101535284B (zh) 2014-12-10
PT2059513E (pt) 2013-04-30
KR20090054464A (ko) 2009-05-29
US20080139818A1 (en) 2008-06-12
RU2495030C2 (ru) 2013-10-10
AU2007292915B2 (en) 2012-07-26
AU2007292915A1 (en) 2008-03-13
TWI482761B (zh) 2015-05-01
CN101535284A (zh) 2009-09-16
US8367841B2 (en) 2013-02-05
MY148598A (en) 2013-05-15
JP2010502715A (ja) 2010-01-28
CA2842625C (en) 2016-07-12
JP2014193896A (ja) 2014-10-09
MX2009002439A (es) 2009-03-27

Similar Documents

Publication Publication Date Title
AR062715A1 (es) Procesos para la preparacion de acidos de 1,2,4- oxadiazol benzoico
DK1678119T3 (da) Fremgangsmåde til fremstilling af 2-dihalogenacyl-3-amino-acrylsyreestere og 3-dihalogenmethyl-pyrazol-4-carboxylsyreestere
ATE451380T1 (de) Verfahren zur herstellung von bisphosphonsäureverbindungen
BR112014014148A2 (pt) misturas de ácidos difosfínicos e dialquilfosfínicos, processo para produção das mesmas e uso das mesmas
EA201490709A1 (ru) Адъювантное соединение
BR112012024403A2 (pt) processo de preparo de derivados de amino-benzofurano
DE602005026310D1 (de) Verfahren zur herstellung von ibandronat
EA201290872A1 (ru) Способ получения бензоксаборолов
ATE537136T1 (de) Neues verfahren zur herstellung von säurechloriden
BR112012005126A8 (pt) Cristalização de 4'-epidaunorubicina x hcl
DE60014088D1 (de) Verfahren zur herstellung von (nitroxymethyl)phenylestern von salicylsäurederivaten
AR059375A1 (es) Procedimiento para produccion de 5-alcoxi-4-hidroximetilpirazol y compuestos
DK1999159T3 (da) Fremgangsmåde til isolering og stabilisering af lavmolekylvægt-aminoglycanforbindelser fra spildæggeskaller
AR057909A1 (es) Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico.
JP2009517412A5 (enExample)
DE60330152D1 (de) Verfahren zur herstellung von nitrooxyderivaten von naproxen
EA200600760A1 (ru) Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их
JP2007045816A5 (ja) カルバゾール誘導体、発光素子用材料として用いられるアントラセン誘導体の作製方法
ATE539071T1 (de) Verfahren zur herstellung von s-(-)-6-hydroxy-2,5,7,8-tetramethylchroman-2-ca bonsäure
PE20070526A1 (es) Metodos para preparar derivados de acido glutamico
EA200501530A1 (ru) Новые соединения бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат
AR127964A1 (es) Sal novedosa de un derivado de 1-sulfonilpirrol, método de preparación de la misma y composición farmacéutica que comprende la misma
AR074151A1 (es) Un derivado de benzoilbencenoacetamida, proceso de preparacion del mismo, forma polimorfica b de dicho compuesto, proceso de obtencion de dicha forma polimorfica b y su uso
BR112012012908A2 (pt) processo de preparo de um derivado de combretastatina
AR058171A1 (es) Procesos para la preparacion de derivados de ciclopropilamida

Legal Events

Date Code Title Description
FC Refusal